About this trial
The goals of this protocol is to diagnose, care for, and understand the clinical histories and outcomes of people with leukodystrophies.
Eligibility criteria
Qualifiers
evidence by clinical exam, radiological findings, and/or testing, of an inherited leukodystrophy.
be able to travel to the leukodystrophy clinic (at Primary Children's Hospital, Salt Lake City, Utah);
be able to tolerate a general physical exam, and a neurological exam.
Disqualifiers
unable to be evaluated at the University of Utah Hospital or Primary Children's Hospital;
refusal to sign study consent form;
evidence or finding of another non-genetic cause of their condition;
Persons with known white matter disease or lesions related to: birth injury or prenatal injury, multiple sclerosis, trauma, infection, immunization, or post-infectious effects (e.g. ADEM- acute disseminated encephalomyelitis), metabolic disturbance (e.g. Central pontine myelinolysis), neoplasms, primary rheumatologic diseases (e.g. Systemic lupus erythematosis), stroke, hypoxic-ischemic injury, drug or toxin effect, seizures, or endocrine disturbance.
Trial design
Treatments tested in this trial
- Not listed